# GSK3739937 First-Time-In-Human (FTIH) Study in Healthy Volunteers

> **NCT04493684** · PHASE1 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 91 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** GSK3739937 (PIB)
- **DRUG:** Placebo
- **DRUG:** GSK3739937 (Tablet)

## Key facts

- **NCT ID:** NCT04493684
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-31
- **Primary completion:** 2021-08-30
- **Final completion:** 2021-08-30
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2025-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04493684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04493684, "GSK3739937 First-Time-In-Human (FTIH) Study in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04493684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*